They are three to five times more frequent in AML patients older than 60 years of age, are mutually exclusive with mutations in NPM1 in this population, and rarely found in combination with FMS related receptor tyrosine kinase 3-internal tandem duplication (FLT3-ITD (134). Here, FLT3 is linked to acute myeloid leukemia.